• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周血流式细胞术在鉴别低级别与高级别骨髓增生异常综合征(MDS)以及血细胞减少评估中的应用。

Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias.

作者信息

Rashidi Hooman H, Xu Xiangdong, Wang Huan-You, Shafi Nelofar Q, Rameshkumar Karuna, Messer Karen, Smith Brian R, Rose Michal G

机构信息

University of California San Diego School of Medicine & VA Medical Center San Diego, USA.

出版信息

Int J Clin Exp Pathol. 2012;5(3):224-30. Epub 2012 Mar 25.

PMID:22558477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3341683/
Abstract

The diagnostic utility of flow cytometry in the evaluation of cytopenias and in the differential diagnosis of low-grade versus high-grade myelodysplastic syndrome (MDS) is not widely appreciated. In this report, we measured granulocyte CD10/control fluorescence ratio in 29 patients with MDS & chronic myelomonocytic leukemia (CMML) using peripheral blood (PB) flow cytometry (FC). We found a lower ratio in high-grade MDS and CMML (mean ratio of 2.2 ± 0.7) vs. low-grade MDS (3.65 ± 0.9) and 16 cytopenic controls without MDS (3.67 ± 0.65; p<0.001). The sensitivity and specificity of CD10 ratio <3 for the group that included the high risk MDS and CMML patients were 87.5% and 100%, respectively. Our data suggests that FC of PB may be helpful in the work-up of patients with cytopenias and in the differential diagnosis of low-grade vs. high-grade MDS.

摘要

流式细胞术在血细胞减少症评估以及低级别与高级别骨髓增生异常综合征(MDS)鉴别诊断中的诊断效用尚未得到广泛认可。在本报告中,我们使用外周血流式细胞术(FC)测量了29例MDS及慢性粒单核细胞白血病(CMML)患者的粒细胞CD10/对照荧光比率。我们发现,高级别MDS和CMML患者的比率较低(平均比率为2.2±0.7),而低级别MDS患者(3.65±0.9)以及16例无MDS的血细胞减少症对照患者(3.67±0.65;p<0.001)的比率较高。对于包括高危MDS和CMML患者的组,CD10比率<3的敏感性和特异性分别为87.5%和100%。我们的数据表明,外周血流式细胞术可能有助于血细胞减少症患者的检查以及低级别与高级别MDS的鉴别诊断。

相似文献

1
Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias.外周血流式细胞术在鉴别低级别与高级别骨髓增生异常综合征(MDS)以及血细胞减少评估中的应用。
Int J Clin Exp Pathol. 2012;5(3):224-30. Epub 2012 Mar 25.
2
[Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].[多参数流式细胞术在慢性粒单核细胞白血病、骨髓增生异常综合征及急性单核细胞白血病免疫表型鉴别中的意义及应用价值]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Aug;20(4):857-62.
3
Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors.通过多参数流式细胞术改善骨髓增生异常综合征与反应性外周血细胞减少症的鉴别诊断:B细胞前体的作用
Diagn Pathol. 2015 Apr 29;10:44. doi: 10.1186/s13000-015-0259-3.
4
Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.多参数流式细胞术有助于区分骨髓增生异常综合征与非肿瘤性血细胞减少症。
Eur J Cancer. 2016 Feb;54:49-56. doi: 10.1016/j.ejca.2015.11.013. Epub 2015 Dec 22.
5
Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?慢性粒单核细胞白血病的免疫表型:它更接近骨髓增生异常综合征还是骨髓增殖性疾病?
Transl Res. 2008 May;151(5):240-5. doi: 10.1016/j.trsl.2008.03.001. Epub 2008 Apr 7.
6
Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia.精氨酸酶1的过表达与低级别骨髓增生异常综合征和慢性粒单核细胞白血病中的DNMT3A和TET2突变有关。
Leuk Res. 2018 Feb;65:5-13. doi: 10.1016/j.leukres.2017.12.003. Epub 2017 Dec 6.
7
Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes: a diagnostic accuracy study.流式细胞术检测外周血中性粒细胞髓过氧化物酶表达在排除骨髓增生异常综合征中的诊断准确性研究。
Haematologica. 2019 Dec;104(12):2382-2390. doi: 10.3324/haematol.2018.202275. Epub 2019 Apr 19.
8
Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies.切断与骨髓增生异常综合征的联系:慢性粒单核细胞白血病的特异性生物学及管理策略
Curr Opin Hematol. 2015 Mar;22(2):163-70. doi: 10.1097/MOH.0000000000000112.
9
A combination of CD15/CD10, CD64/CD33, CD16/CD13 or CD11b flow cytometric granulocyte panels is sensitive and specific for diagnosis of myelodysplastic syndrome.CD15/CD10、CD64/CD33、CD16/CD13或CD11b流式细胞术粒细胞检测组合对骨髓增生异常综合征的诊断具有敏感性和特异性。
Ann Clin Lab Sci. 2012 Summer;42(3):271-80.
10
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group.多中心前瞻性评估 ELN iMDS 流式工作组在骨髓增生异常综合征中流式细胞术异常的诊断潜力。
Cytometry B Clin Cytom. 2023 Jan;104(1):51-65. doi: 10.1002/cyto.b.22105. Epub 2022 Nov 23.

引用本文的文献

1
MDS-PB13 Score - Blood based detection of aberrancies by flow cytometry in patients with suspected and confirmed Myelodysplastic Neoplasms.MDS-PB13评分——通过流式细胞术对疑似和确诊骨髓增生异常综合征患者进行基于血液的异常检测。
Leukemia. 2024 Feb;38(2):446-450. doi: 10.1038/s41375-024-02141-w. Epub 2024 Jan 16.
2
Comparative diagnostic accuracy between simplified and original flow cytometric gating strategies for peripheral blood neutrophil myeloperoxidase expression in ruling out myelodysplastic syndromes.简化和原始流式细胞术门控策略对外周血中性粒细胞髓过氧化物酶表达在排除骨髓增生异常综合征中的比较诊断准确性。
PLoS One. 2022 Nov 18;17(11):e0276095. doi: 10.1371/journal.pone.0276095. eCollection 2022.
3
Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet.流式细胞术分析骨髓增生异常:分析前和技术问题-欧洲白血病网络的建议。
Cytometry B Clin Cytom. 2023 Jan;104(1):15-26. doi: 10.1002/cyto.b.22046. Epub 2021 Dec 11.
4
Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression for ruling out myelodysplastic syndromes: a prospective validation study.流式细胞术检测外周血中性粒细胞髓过氧化物酶表达在排除骨髓增生异常综合征中的应用:一项前瞻性验证研究。
Ann Hematol. 2021 May;100(5):1149-1158. doi: 10.1007/s00277-021-04446-7. Epub 2021 Feb 10.
5
Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes: a diagnostic accuracy study.流式细胞术检测外周血中性粒细胞髓过氧化物酶表达在排除骨髓增生异常综合征中的诊断准确性研究。
Haematologica. 2019 Dec;104(12):2382-2390. doi: 10.3324/haematol.2018.202275. Epub 2019 Apr 19.
6
A pilot study on the usefulness of peripheral blood flow cytometry for the diagnosis of lower risk myelodysplastic syndromes: the "MDS thermometer".外周血流式细胞术在低危骨髓增生异常综合征诊断中的应用初步研究:“MDS温度计”
BMC Hematol. 2018 Mar 13;18:6. doi: 10.1186/s12878-018-0101-8. eCollection 2018.
7
Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.一项多中心研究强调,在骨髓增生异常综合征和骨髓增生异常/骨髓增殖性肿瘤中,将CD5、CD7和CD56表达评估添加到流式细胞术绪方评分中的意义。
Haematologica. 2015 Apr;100(4):472-8. doi: 10.3324/haematol.2014.112755. Epub 2015 Jan 30.
8
Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.重新审视流式细胞术结果在 WHO 骨髓增生异常综合征分类中的整合指南——国际/欧洲白血病网流式细胞术工作组的建议。
Leukemia. 2014 Sep;28(9):1793-8. doi: 10.1038/leu.2014.191. Epub 2014 Jun 12.
9
Management recommendations for chronic myelomonocytic leukemia: consensus statements from the SIE, SIES, GITMO groups.慢性粒单核细胞白血病的管理建议:来自 SIE、SIES、GITMO 小组的共识声明。
Haematologica. 2013 Sep;98(9):1344-52. doi: 10.3324/haematol.2013.084020.

本文引用的文献

1
The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders.非急性髓系疾病中原始细胞免疫表型改变的特异性。
Am J Clin Pathol. 2010 Nov;134(5):749-61. doi: 10.1309/AJCPFNF5MN1GDWKU.
2
The impact of several phenotypic features at diagnosis on survival of patients with myelodysplastic syndromes.几种表型特征在诊断时对骨髓增生异常综合征患者生存的影响。
Neoplasma. 2010;57(6):530-6. doi: 10.4149/neo_2010_06_530.
3
Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.诊断骨髓增生异常/骨髓增殖性肿瘤:排除其他疾病的实验室检测策略。
Int J Lab Hematol. 2010 Dec;32(6 Pt 2):559-71. doi: 10.1111/j.1751-553X.2010.01251.x.
4
Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data.多参数流式细胞术在诊断 1013 例疑似骨髓增生异常综合征患者中的临床应用:与细胞形态学、细胞遗传学和临床资料的相关性。
Cancer. 2010 Oct 1;116(19):4549-63. doi: 10.1002/cncr.25353.
5
Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes.流式细胞术积分系统(FCMSS)辅助诊断骨髓增生异常综合征(MDS)及基于 FCMSS 的免疫表型的生物学意义。
Br J Haematol. 2010 May;149(4):587-97. doi: 10.1111/j.1365-2141.2010.08146.x. Epub 2010 Mar 16.
6
Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.骨髓细胞多发性骨髓发育不良综合征表现出改变的免疫表型特征,可能有助于疾病的诊断和预后分层:对 56 例患者系列的初步研究。
Cytometry B Clin Cytom. 2010 May;78(3):154-68. doi: 10.1002/cyto.b.20513.
7
Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry.髓系粒细胞的免疫表型:流式细胞术鉴别骨髓增生异常综合征和再生障碍性贫血的初步研究。
Int J Lab Hematol. 2010 Jun;32(3):275-81. doi: 10.1111/j.1751-553X.2009.01192.x. Epub 2009 Nov 30.
8
Myelodysplastic syndromes.骨髓增生异常综合征
N Engl J Med. 2009 Nov 5;361(19):1872-85. doi: 10.1056/NEJMra0902908.
9
Myelodysplastic syndromes: the role of flow cytometry in diagnosis and prognosis.骨髓增生异常综合征:流式细胞术在诊断和预后中的作用
Int J Lab Hematol. 2009 Oct;31(5):479-83. doi: 10.1111/j.1751-553X.2009.01176.x. Epub 2009 Jun 25.
10
Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study.流式细胞术在低级别骨髓增生异常综合征中的诊断效用:一项前瞻性验证研究。
Haematologica. 2009 Aug;94(8):1066-74. doi: 10.3324/haematol.2009.008532. Epub 2009 Jun 22.